戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  (zero for bacterial vaginosis, candida, and Trichomonas vaginalis).
2 ) and three partial draft genomes (including Trichomonas vaginalis).
3 drial protist pathogens: Giardia lamblia and Trichomonas vaginalis.
4 , Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis.
5 t preparation and a culture method to detect Trichomonas vaginalis.
6 Trypanosoma brucei, Leishmania donovani, and Trichomonas vaginalis.
7 in one of the earliest diverging protozoans, Trichomonas vaginalis.
8  is specifically related to a homologue from Trichomonas vaginalis.
9 a, that represented by the parasitic protist Trichomonas vaginalis.
10 ctably transform the human-infective protist Trichomonas vaginalis.
11 ption of protein-coding genes of the protist Trichomonas vaginalis.
12 as been proposed as a possible treatment for Trichomonas vaginalis.
13 st the urogenital, nonkinetoplastid parasite Trichomonas vaginalis.
14 nomer (rTvCyP1 mono) from the human pathogen Trichomonas vaginalis.
15 e causative agent is the parasitic protozoan Trichomonas vaginalis.
16 aginotropic extracellular protozoan parasite Trichomonas vaginalis.
17 nscription factor in the protozoan parasite, Trichomonas vaginalis.
18 for Candida spp., Gardnerella vaginalis, and Trichomonas vaginalis.
19 ally transmitted infections (STIs) caused by Trichomonas vaginalis.
20                   Women were also tested for Trichomonas vaginalis.
21 sekeeping genes, to genetically characterize Trichomonas vaginalis.
22 bation of culture media for the detection of Trichomonas vaginalis.
23 terium Anabaena sp. (44%), and the protozoan Trichomonas vaginalis (46%), which targets its POR to an
24                                              Trichomonas vaginalis, a common sexually transmitted par
25                                              Trichomonas vaginalis, a flagellated protozoan, is the a
26                                              Trichomonas vaginalis, a human-infective parasite, cause
27                                           In Trichomonas vaginalis, a Myb1 protein was previously dem
28                                           In Trichomonas vaginalis, a parabasalian flagellate thought
29                                  Among them, Trichomonas vaginalis, a parasite adapted to the human g
30  describe the genome sequence of the protist Trichomonas vaginalis, a sexually transmitted human path
31 is (BV), vulvovaginal candidiasis (VVC), and Trichomonas vaginalis accounts for a significant proport
32 hlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, adenovirus, and herpes simplex vi
33  there was some evidence of association with Trichomonas vaginalis (adjusted OR, 1.56; 95% CI, 1.00-2
34 d Entamoeba histolytica, and the parabasalid Trichomonas vaginalis all belong to Class II of FBAs and
35 ribed in the divergent unicellular eukaryote Trichomonas vaginalis, although genome analyses reveal t
36                           The discovery that Trichomonas vaginalis, an early diverging protist that l
37  7,899 specimens submitted for live clinical Trichomonas vaginalis analyte-specific reagent (ASR) scr
38 o transcription-mediated amplification-based Trichomonas vaginalis analyte-specific-reagent (ASR) tes
39 s specific, since the related human parasite Trichomonas vaginalis and associated purified CPs did no
40 ption-mediated amplification (TMA) assay for Trichomonas vaginalis and BTUB FRET PCR, using self-obta
41 drial carrier family in the hydrogenosome of Trichomonas vaginalis and have shown that this protein,
42 icient in metronidazole-resistant strains of Trichomonas vaginalis and is thought to be necessary for
43                                   Additional Trichomonas vaginalis and Mycoplasma genitalium screenin
44 sence of a splicing apparatus in the protist Trichomonas vaginalis and show that RNA motifs found in
45 ent in the amitochondriate parasitic protist Trichomonas vaginalis and some but not all other trichom
46                                              Trichomonas vaginalis and viral pathogens (herpes simple
47 hlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis) and the E6/E7 mRNA of human papil
48 lastida (Leishmania major), the Parabasalia (Trichomonas vaginalis), and the Microsporidia (Vairimorp
49 hlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and bacterial vaginosis have been
50 hlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and bacterial vaginosis testing w
51 ptococcus agalactiae, Chlamydia trachomatis, Trichomonas vaginalis, and Candida spp., as well as thei
52  the pathogenic protozoa Giardia lamblia and Trichomonas vaginalis, and the bacterial pathogens Helic
53  the slime-mold Dictyostelium, the protozoan Trichomonas vaginalis, and the bacterium Burkholderia ps
54 ntamoeba fragilis, Pentatrichomonas hominis, Trichomonas vaginalis, and Trichomonas tenax.
55               The parasite he discovered was Trichomonas vaginalis; and, in collaboration with Foucau
56 ing Giardia lamblia, Leishmania species, and Trichomonas vaginalis are persistently infected with dsR
57 omonas vaginalis prevalence using the Aptima Trichomonas vaginalis assay (ATV; Gen-Probe) and the pre
58 ts of a commercial NAA test (GenProbe Aptima Trichomonas vaginalis assay; ATV) for T. vaginalis were
59 ologically assayed chlamydia, gonorrhea, and Trichomonas vaginalis) at the 12-month assessment and th
60 clinic for a new complaint were screened for Trichomonas vaginalis by culture and by PCR analysis of
61 on as well as to determine the prevalence of Trichomonas vaginalis by culture in a large and diverse
62 amplification tests (NAATs) for detection of Trichomonas vaginalis by vaginal swabs; NAATs for detect
63 clinic for a new complaint were screened for Trichomonas vaginalis by wet-preparation (wet-prep) micr
64 he three common organisms causing vaginitis: Trichomonas vaginalis, Candida species, and Gardnerella
65     Deidentified clinical data and tests for Trichomonas vaginalis, Candida, and bacterial vaginosis
66                                              Trichomonas vaginalis causes the most common, nonviral s
67                 The human-infective parasite Trichomonas vaginalis causes the most prevalent nonviral
68                                The protozoan Trichomonas vaginalis colonizes the human urogenital tra
69                                              Trichomonas vaginalis colonizes the urogenital tract of
70                   The extracellular parasite Trichomonas vaginalis contains a surface glycoconjugate
71 om Trypanosoma cruzi, Entamoeba histolytica, Trichomonas vaginalis, Cryptococcus neoformans, and Sacc
72 thral swabs were obtained at enrollment, for Trichomonas vaginalis culture; semen specimens were also
73 n of macaques with Chlamydia trachomatis and Trichomonas vaginalis decreases the prophylactic efficac
74  determine if secreted cysteine proteases of Trichomonas vaginalis degrade SLPI and render it nonfunc
75 condary test in improving the sensitivity of Trichomonas vaginalis detection in young women over that
76           This study compared two assays for Trichomonas vaginalis detection, Gen-Probe's transcripti
77 obe was designed and evaluated for detecting Trichomonas vaginalis DNA in a 5' nuclease (TaqMan) assa
78 ydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis DNA, detected using the BD MAX CT/
79 polymerase chain reaction (PCR) analysis for Trichomonas vaginalis DNA.
80                               Infection with Trichomonas vaginalis during pregnancy has been associat
81 eria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis, each considered separately) and i
82 eisseria gonorrhoeae (males and females) and Trichomonas vaginalis (females only) offered over 12 mon
83        The crystal structure of the oxidized Trichomonas vaginalis ferredoxin (Tvfd) showed a unique
84 odified medium to InPouch for the culture of Trichomonas vaginalis from pooled vaginal secretions.
85                         Two genes coding for Trichomonas vaginalis glucokinase were isolated and sequ
86 ase (PPi-PFK) of the amitochondriate protist Trichomonas vaginalis has been purified.
87          The utility of TMA for detection of Trichomonas vaginalis has recently been described.
88 tica, Leishmania spp., Trypanosoma cruzi and Trichomonas vaginalis have genes encoding homologues of
89         Nucleic acid amplification tests for Trichomonas vaginalis have improved sensitivity for dete
90  Giardia lamblia, Entamoeba histolytica, and Trichomonas vaginalis have robust oxygen consumption sys
91 l vaginosis (vaginal pH of 5.0 or above) and Trichomonas vaginalis (immunoassay) regardless of sympto
92 plasma genitalium, Chlamydia trachomatis, or Trichomonas vaginalis in 10 patients (8%).
93 ydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in liquid-based cytology specimens
94  could also detect Mycoplasma genitalium and Trichomonas vaginalis in men and women reporting a histo
95               The impact of the viability of Trichomonas vaginalis in urine on wet mount, culture, an
96                                              Trichomonas vaginalis infected with a double-stranded RN
97 l SLPI levels have been correlated with both Trichomonas vaginalis infection and poor reproductive he
98                                              Trichomonas vaginalis infection in males has been largel
99                                              Trichomonas vaginalis infection in men is an important c
100 ed to wet mount and PCR for the diagnosis of Trichomonas vaginalis infection in women.
101                                              Trichomonas vaginalis infection is a sexually transmitte
102                                              Trichomonas vaginalis infection is estimated to be the m
103                            The prevalence of Trichomonas vaginalis infection is highest in women with
104                                              Trichomonas vaginalis infection is highly prevalent worl
105                                              Trichomonas vaginalis infection is highly prevalent, may
106                                              Trichomonas vaginalis infection is the most prevalent no
107 omen in Mombasa, Kenya, to determine whether Trichomonas vaginalis infection was associated with an i
108 = 756 men), we identified 150 men (20%) with Trichomonas vaginalis infection, 358 men (47%) with HIV
109 ns related to the diagnosis and treatment of Trichomonas vaginalis infection, as well as the associat
110  long-acting reversible contraception usage, Trichomonas vaginalis infection, bacterial vaginosis, an
111 esented regarding conditions associated with Trichomonas vaginalis infection, including human immunod
112 k women, being 30 to 40 years of age, recent Trichomonas vaginalis infection, primary or recurrent ge
113  infection, Chlamydia trachomatis infection, Trichomonas vaginalis infection, vulvovaginal candidiasi
114 ydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infection.
115 eria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis infection.
116                                              Trichomonas vaginalis infections are usually asymptomati
117 eria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis infections as well as the characte
118                                              Trichomonas vaginalis infections in men are traditionall
119 tudy was to evaluate potential mechanisms of Trichomonas vaginalis involvement in human immunodeficie
120                                              Trichomonas vaginalis is a common sexually transmitted i
121                                              Trichomonas vaginalis is a common sexually transmitted p
122                                              Trichomonas vaginalis is a common, extracellular, sexual
123                                              Trichomonas vaginalis is a highly divergent, unicellular
124                                              Trichomonas vaginalis is a parasite of the urogenital tr
125                                              Trichomonas vaginalis is a parasitic protozoan and the c
126                                              Trichomonas vaginalis is a parasitic protozoan purine au
127                                              Trichomonas vaginalis is a prevalent sexually transmitte
128                                              Trichomonas vaginalis is a protist that causes the most
129                                              Trichomonas vaginalis is a protozoan parasite of humans
130                                              Trichomonas vaginalis is a unicellular microaerophilic e
131                                              Trichomonas vaginalis is an anaerobic protozoan parasite
132                                              Trichomonas vaginalis is an extracellular protozoan para
133                                              Trichomonas vaginalis is an important pathogen in both m
134                                              Trichomonas vaginalis is an underestimated sexually tran
135                           Host parasitism by Trichomonas vaginalis is complex and in part mediated by
136                           Host parasitism by Trichomonas vaginalis is complex, and the adhesion to va
137 from the sexually transmitted human parasite Trichomonas vaginalis is described.
138                                              Trichomonas vaginalis is likely the most prevalent nonvi
139                                  The protist Trichomonas vaginalis is one of the most common human se
140                                              Trichomonas vaginalis is one of the most common nonviral
141 ecreted cysteine protease (CP) fraction from Trichomonas vaginalis is shown here to induce apoptosis
142                                              Trichomonas vaginalis is the agent of a highly prevalent
143                                              Trichomonas vaginalis is the most prevalent nonviral sex
144                                              Trichomonas vaginalis is the most prevalent nonviral sex
145                                              Trichomonas vaginalis is the most prevalent nonviral sex
146 udy were to examine the TVV prevalence in US Trichomonas vaginalis isolates and TVV's associations wi
147 hlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma hominis, Ureaplasma sp
148 es inoculated with Chlamydia trachomatis and Trichomonas vaginalis (n = 9) or medium (controls; n = 7
149                               With gap1 from Trichomonas vaginalis obtained earlier, the data include
150  unusual case of extragenital infection with Trichomonas vaginalis of the conjunctiva of a 32-year-ol
151 rican women who used drugs were screened for Trichomonas vaginalis on > or =2 occasions between March
152 230) performed rapid point-of-care tests for Trichomonas vaginalis on self-collected vaginal swabs.
153 ated in patients concomitantly infected with Trichomonas vaginalis or Chlamydia trachomatis in additi
154 isseria gonorrhea, Chlamydia trachomatis, or Trichomonas vaginalis or who had a rapid antigen or posi
155   Women infected with Neisseria gonorrhoeae, Trichomonas vaginalis, or Chlamydia trachomatis had high
156 en, infections with Neisseria gonorrhoeae or Trichomonas vaginalis, or long-term follow-up.
157 ins AP65, AP51, AP33 and AP23 synthesized by Trichomonas vaginalis organisms in high iron play a role
158 culture and evaluated their interaction with Trichomonas vaginalis parasites to complement previous s
159 at immune cells perform trogocytosis to kill Trichomonas vaginalis parasites.
160                                              Trichomonas vaginalis PCR using reagents from a commerci
161 pid antigen or positive urine microscopy for Trichomonas vaginalis performed.
162 fungal pathogens, as well as protozoa, e.g., Trichomonas vaginalis, Plasmodium berghei, and sporozoit
163                     Our aim was to determine Trichomonas vaginalis prevalence using the Aptima Tricho
164                                              Trichomonas vaginalis produces soluble factors that have
165 rhoeae (nucleic acid amplification test) and Trichomonas vaginalis (rapid immunochromatographic assay
166                                              Trichomonas vaginalis relies on imported purine and pyri
167 the genome databases for Giardia lamblia and Trichomonas vaginalis, respectively, and represent the l
168 e (rSAHH) cloned from Pseudomonas putida and Trichomonas vaginalis, respectively.
169                                              Trichomonas vaginalis results were concordant between th
170 binding protein from the primitive eukaryote Trichomonas vaginalis reveals how a single protein can o
171 s the gold standard for clinical culture for Trichomonas vaginalis screening.
172                          Our analyses of the Trichomonas vaginalis SCS sequences also confirmed the m
173                                              Trichomonas vaginalis secretes putrescine that is readil
174 ydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Sequencing was used to assess macr
175                 A related human trichomonad, Trichomonas vaginalis, showed no cytotoxic effects, indi
176 the amitochondrial Entamoeba histolytica and Trichomonas vaginalis species were analyzed.
177                                  The InPouch Trichomonas vaginalis test is the gold standard for clin
178 aginalis were compared with the Affirm VPIII Trichomonas vaginalis test.
179 r point-of-care test (POCT) for the parasite Trichomonas vaginalis that causes the STI trichomoniasis
180 hydrogenosome-bearing, unicellular eukaryote Trichomonas vaginalis, that contains the active site mot
181                                              Trichomonas vaginalis, the causative agent for human tri
182                                              Trichomonas vaginalis, the causative agent of the venere
183            Recent studies have proposed that Trichomonas vaginalis, the causative agent of trichomoni
184                                              Trichomonas vaginalis, the etiologic agent of the most c
185 e medically important parasites: the protist Trichomonas vaginalis, the hard tick Ixodes ricinus, and
186      Trichomoniasis results from adhesion of Trichomonas vaginalis to the mucous membrane of the uret
187  2 (HSV-2), syphilis, chlamydia, gonorrhoea, Trichomonas vaginalis (together defined as 'any STI') an
188 iterature has reported increased accuracy of Trichomonas vaginalis transcription-mediated amplificati
189 as been associated with an increased risk of Trichomonas vaginalis (TV) acquisition, it is unknown wh
190 oth prevalent and persistent infections with Trichomonas vaginalis (TV) are common.
191 omatis (CT), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV) are sexually transmitted infe
192                                              Trichomonas vaginalis (TV) can be infected with double-s
193 ), Neisseria gonorrhoeae (NG), syphilis, and Trichomonas vaginalis (TV) diagnosed in pregnancy among
194 f human immunodeficiency virus transmission, Trichomonas vaginalis (TV) infection constitutes an impo
195 n is affected by bacterial vaginosis (BV) or Trichomonas vaginalis (TV) infection has not been adequa
196 is (BV), vulvovaginal candidiasis (VVC), and Trichomonas vaginalis (TV) is not standardized.
197                                              Trichomonas vaginalis (TV) is the most common nonviral s
198                                              Trichomonas vaginalis (TV) results were compared relativ
199              All clinics used POC assays for Trichomonas vaginalis (TV) testing.
200 lagellar components required for the protist Trichomonas vaginalis (Tv) to swim through the human gen
201  Ureaplasma urealyticum biovar 2 (UU-2), and Trichomonas vaginalis (TV) using nucleic acid amplificat
202 ally transmitted infections (STIs) caused by Trichomonas vaginalis (TV), Chlamydia trachomatis (CT),
203 mammalian cells and protozoan parasites like Trichomonas vaginalis (Tv), the cause of the most common
204 sis (BV), vulvovaginal candidiasis (VVC), or Trichomonas vaginalis (TV), were randomly assigned to re
205  study assessed the performance of the cobas Trichomonas vaginalis (TV)/MG assay (cobas) for the dete
206 xidized form of the [2Fe-2S] ferredoxin from Trichomonas vaginalis (TvFd) are presented.
207 s simplex virus 2 infection, genital ulcers, Trichomonas vaginalis, vaginitis or cervicitis, and male
208 ydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis via commercial transcription-media
209                                              Trichomonas vaginalis virus (TVV) is a non-segmented, 4.
210 LV was found to be more thermoresistant than Trichomonas vaginalis virus 1, but no specific protein m
211 iruses, including Leishmania RNA viruses and Trichomonas vaginalis viruses.
212                       GPI of the parabasalid Trichomonas vaginalis was also sequenced.
213 ransport medium to maintain the viability of Trichomonas vaginalis was determined by comparing transp
214 CR assay, using primers against pfoB gene of Trichomonas vaginalis, was developed and evaluated using
215 DNA detection, but Chlamydia trachomatis and Trichomonas vaginalis were not.
216 eria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis were performed.
217                                              Trichomonas vaginalis, which causes the most common nonv
218 equences in the protists Giardia lamblia and Trichomonas vaginalis, which may represent the deepest k
219 tein-encoding genes in the parasitic protist Trichomonas vaginalis, which represents one of the deepe

 
Page Top